The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.
Eligibility
Sex
FEMALE
Min age
30 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria:
* • Women with suspicious breast mass (BIRADS 4a)
* High risk women (Positive family history)
* Women with suspicious axillary lymph nodes by Ultrasound
* Women with dense breasts coming for MRI imaging.
Exclusion Criteria:
* • Contraindications to MRI
* Pacemaker, cochlear implant, claustrophobia, ocular implants
* Contraindications to contrast administration:
* Elevated kidney functions
* Women who haven't undergone reliable Mammogram \& Ultrasound
* Women with prior treatment or intervention (e.g. biopsy)
* Patients' refusal.
Primary outcome measure(s)
To evaluate the capability of detecting suspicious breast lesions using non-contrast enhanced MRI protocol featuring ultra-high B-value — 20 months
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.